Skip to main content
Log in

Nanomedicine

Barcodes check out prostate cancer

  • News & Views
  • Published:

From Nature Nanotechnology

View current issue Submit your manuscript

An assay based on gold nanoparticles could detect recurrences of prostate cancer sooner than is possible with existing techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: A bio-barcode assay for prostate specific antigen.

References

  1. Freedland, S. J. & Moul, J. W. J. Urol. 177, 1985–1991 (2007).

    Article  Google Scholar 

  2. Thaxton, C. S. et al. Proc. Natl Acad. Sci. USA 106, 18437–18442 (2009).

    Article  CAS  Google Scholar 

  3. Barry, M. J. N. Engl. J. Med. 360, 1351–1354 (2009).

    Article  CAS  Google Scholar 

  4. Healy, D. A. et al. Trends Biotechnol. 25, 125–131 (2007).

    Article  CAS  Google Scholar 

  5. Thompson, I. M. et al. J. Natl Cancer Inst. 98, 529–534 (2006).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hearty, S., Leonard, P. & O'Kennedy, R. Barcodes check out prostate cancer. Nature Nanotech 5, 9–10 (2010). https://doi.org/10.1038/nnano.2009.459

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nnano.2009.459

  • Springer Nature Limited

This article is cited by

Navigation